Successful Fundraising Event for Melanoma Research
The enthusiastic response from finance professionals showcased a commitment to fighting melanoma. Recently, the inaugural Leveraged Finance Fights Melanoma (LFFM) charity event took place at The National Gallery, attracting over 600 attendees and raising a remarkable £1.4 million. This event served as a significant expansion of the LFFM initiative that originally launched in New York City, now reaching a global audience.
Transformative Impact of Fundraising
Stephanie Kauffman, the president of the Melanoma Research Alliance, emphasized the transformative impact of the funds raised. "This generous support allows us to keep investing in brilliant researchers in the UK, equipping them with vital resources necessary to push the frontiers of melanoma research and enhance patient outcomes both domestically and globally," she stated.
A Global Commitment to Cancer Research
The event was co-founded by Jeff Rowbottom and Brendan Dillon, both of whom are melanoma survivors. "This expansion reflects the collective commitment of our community to drive innovation in cancer research," remarked Rowbottom. LFFM has successfully raised over £22 million since its inception in 2011, highlighting the powerful synergy among professionals in the leveraged finance and private equity sectors as they come together to support this important cause.
Prominent Leadership and Sponsorship
Co-chaired by well-known leaders in the finance sector, the event hosted industry giants as sponsors. Key figures included Roxana Mirica from Apax Partners, Leo Wouters from General Atlantic, and Sean Costello from Fitch, among others. Their combined efforts emphasize the strength of collaboration in tackling melanoma.
Significance of Support from the Finance Sector
This charitable effort not only raises funds but also fosters awareness about the challenges faced by melanoma patients and the importance of ongoing research. With significant backing from organizations like Veritas Capital and Paul Weiss, participants aim to showcase how financial resources drive advancements in cancer treatment.
Future of Cancer Research Initiatives
The success of the LFFM event illustrates a growing desire within the finance sector to contribute meaningfully to healthcare solutions. As research progresses, continued support will be pivotal in achieving breakthroughs that can save lives.
About the Melanoma Research Alliance
Founded in 2007 by Debra and Leon Black, the Melanoma Research Alliance is a leading non-profit organization dedicated to advancing melanoma research. By providing essential funding, MRA aims to eradicate suffering and death due to melanoma. With a proven track record of catalyzing significant breakthroughs in treatment options, MRA supports innovative researchers exploring all aspects of melanoma.
Frequently Asked Questions
What is the purpose of the LFFM event?
The LFFM event aims to raise funds for melanoma research and create awareness about the disease.
How much money was raised during the event?
A total of £1.4 million was raised, which will support researchers in pursuing crucial melanoma studies.
Who were the key figures involved in LFFM?
The event was co-founded by Brendan Dillon and Jeff Rowbottom, both of whom are melanoma survivors.
What impact does this fundraising have on melanoma research?
The funds will provide vital resources for UK-based researchers, facilitating the advancement of innovative treatments.
How can people get involved in supporting melanoma research?
People can contribute by attending future events, donating, or spreading awareness about melanoma research initiatives.
